172 related articles for article (PubMed ID: 11401957)
21. Acellular pertussis vaccines in China.
Wang L; Lei D; Zhang S
Vaccine; 2012 Nov; 30(50):7174-8. PubMed ID: 23084855
[TBL] [Abstract][Full Text] [Related]
22. A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines.
McGuirk P; Mills KH
Infect Immun; 2000 Mar; 68(3):1383-90. PubMed ID: 10678951
[TBL] [Abstract][Full Text] [Related]
23. New pertussis vaccination approaches: en route to protect newborns?
Locht C; Mielcarek N
FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832
[TBL] [Abstract][Full Text] [Related]
24. Roads to the development of improved pertussis vaccines paved by immunology.
Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
[TBL] [Abstract][Full Text] [Related]
25. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
[TBL] [Abstract][Full Text] [Related]
26. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.
Mills KH; Ryan M; Ryan E; Mahon BP
Infect Immun; 1998 Feb; 66(2):594-602. PubMed ID: 9453614
[TBL] [Abstract][Full Text] [Related]
27. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
[TBL] [Abstract][Full Text] [Related]
28. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model.
Kavanagh H; Noone C; Cahill E; English K; Locht C; Mahon BP
Clin Exp Allergy; 2010 Jun; 40(6):933-41. PubMed ID: 20184606
[TBL] [Abstract][Full Text] [Related]
29. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
[TBL] [Abstract][Full Text] [Related]
30. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands.
David S; Vermeer-de Bondt PE; van der Maas NA
Vaccine; 2008 Oct; 26(46):5883-7. PubMed ID: 18775463
[TBL] [Abstract][Full Text] [Related]
31. IL-1beta-dependent neurological effects of the whole cell pertussis vaccine: a role for IL-1-associated signalling components in vaccine reactogenicity.
Armstrong ME; Loscher CE; Lynch MA; Mills KH
J Neuroimmunol; 2003 Mar; 136(1-2):25-33. PubMed ID: 12620640
[TBL] [Abstract][Full Text] [Related]
32. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
David S; van Furth R; Mooi FR
Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children.
Lacombe K; Yam A; Simondon K; Pinchinat S; Simondon F
Vaccine; 2004 Dec; 23(5):623-8. PubMed ID: 15542182
[TBL] [Abstract][Full Text] [Related]
35. Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines.
Hale C; Humphreys IR; Hussell T; Bowe F; Clare S; Pickard D; Preston A; Del Giudice G; Dougan G
Vaccine; 2004 Sep; 22(27-28):3595-602. PubMed ID: 15315838
[TBL] [Abstract][Full Text] [Related]
36. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
van den Berg BM; David S; Beekhuizen H; Mooi FR; van Furth R
Vaccine; 2000 Dec; 19(9-10):1118-28. PubMed ID: 11137247
[TBL] [Abstract][Full Text] [Related]
37. T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.
Ausiello CM; Lande R; Stefanelli P; Fazio C; Fedele G; Palazzo R; Urbani F; Mastrantonio P
Clin Diagn Lab Immunol; 2003 Jul; 10(4):637-42. PubMed ID: 12853397
[TBL] [Abstract][Full Text] [Related]
38. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
Witt MA; Katz PH; Witt DJ
Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
[TBL] [Abstract][Full Text] [Related]
39. A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines.
Steinhoff MC; Reed GF; Decker MD; Edwards KM; Englund JA; Pichichero ME; Rennels MB; Anderson EL; Deloria MA; Meade BD
Pediatrics; 1995 Sep; 96(3 Pt 2):567-70. PubMed ID: 7659477
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the immune response induced by pertussis OMVs-based vaccine.
Bottero D; Gaillard ME; Zurita E; Moreno G; Martinez DS; Bartel E; Bravo S; Carriquiriborde F; Errea A; Castuma C; Rumbo M; Hozbor D
Vaccine; 2016 Jun; 34(28):3303-9. PubMed ID: 27151884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
